Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b) 500-count bottles (NDC 62756-185-13), c)1000-count bottles (NDC 62756-185-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Published December 28, 2022 · Recall initiated: December 1, 2022
Summary
FDA records drug Class II recall D-0085-2023, published December 28, 2022 and initiated December 1, 2022. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Terminated; Reported quantity: Lot HAC1474A: 4296 Bottles, Lot HAC1474B: 145 Bottles, Lot HAC1503A: 2124 Bottles; Lot: a) Lot HAC1474A, Expires 03/2023 b) Lot HAC1503A, Expires 03/2023 c) Lot HAC1474B, Expires 03/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign substance
What to do
Voluntary: Firm initiated
Get an email if OXCARBAZEPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- OXCARBAZEPINE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- Nationwide within the United States
- UPC
- 0362756183834
- Lot
- a) Lot HAC1474A, Expires 03/2023 b) Lot HAC1503A, Expires 03/2023 c) Lot HAC1474B, Expires 03/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGlycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., EastDecember 28, 2022
- FDAQuinapril Tablets USP, 40 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,December 28, 2022
- FDADeRoyal TRACECART POSTEROR LAMI MICRODISC TRACECART, REF 53-1960.02December 21, 2022
- FDADeRoyal TRACECART POSTEROR LUMBAR FUSION TRACECART, REF 53-1961.02December 21, 2022
- FDADeRoyal CNRV PERIPHERAL VAS PACK, REF 89-10530.03December 21, 2022
- FDAOxcarbazepine Tablets, 300 mg, 100 tablet bottles, Rx Only. Distributed by: Caraco PharmaceuticalFebruary 19, 2014
Questions about this recall
Was Oxcarbazepine Tablets 600mg, packaged in a) 100- count bottles (NDC 62756-185-88), b) 500-count bottles (NDC 62756-185-13), c)1000-count bottles (NDC 62756-185-18), Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Halol-Baroda Highway, Halol-389 350, Gujarat, India. recalled?
Yes. FDA published recall D-0085-2023 on December 28, 2022. Reported hazard: Presence of foreign substance
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: OXCARBAZEPINE. UPC: 0362756183834.